Press release
Migraine Drugs Market 2024-2031: Advancements in CGRP Inhibitors, Biologics, and Targeted Therapies Driving Exponential Growth | AstraZeneca plc, Abbott Laboratories, Eisai Co., Ltd
Migraine Drugs Market
The migraine drugs market refers to the pharmaceutical sector focused on the development, production, and commercialization of medications that treat or prevent migraines-a neurological condition characterized by recurring headaches and associated symptoms like nausea, light sensitivity, and visual disturbances. This market includes drug classes such as triptans, gepants, ditans, ergot alkaloids, NSAIDs, and preventive biologics targeting CGRP. It is driven by the rising global prevalence of migraine, growing awareness of treatment options, and advancements in targeted therapies. The demand for both acute and preventive migraine treatments is increasing, particularly in women and working-age populations. Pharmaceutical innovation and strategic partnerships are enhancing therapeutic pipelines and market reach globally.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Migraine Drugs Market Landscape:- https://datamintelligence.com/download-sample/migraine-drugs-market?rk
☛ Migraine Drugs Market Recent Developments 2025:
United States: Recent Migraine Drug Developments
✅ In January 2025, the FDA approved Axsome Therapeutics' Symbravo (meloxicam/rizatriptan) for acute migraine treatment. This oral combination aims to provide rapid and sustained relief for adults with moderate to severe migraines.
✅ In August 2025, the FDA expanded the indication for Teva's AJOVY (fremanezumab) to include pediatric patients aged 6-17 for episodic migraine prevention. This makes it the first anti-CGRP therapy approved for this age group.
✅ In May 2025, the FDA approved Satsuma Pharmaceuticals' STS101 nasal powder (Atzumi) for acute migraine treatment. This dihydroergotamine nasal powder is the first of its kind approved for adult use.
Japan: Recent Migraine Drug Developments
✅ In May 2025, UCB received approval in Japan for two new administration methods for RYSTIGGO® (rozanolixizumab). These methods allow for self-administration at home, enhancing patient convenience.
✅ In September 2025, Otsuka Pharmaceutical obtained exclusive rights in Japan to develop and commercialize Teva's fremanezumab (AJOVY). The preventive migraine treatment is now available in an auto-injector dosage form.
✅ In May 2025, Satsuma Pharmaceuticals' STS101 nasal powder (Atzumi) received approval in Japan for the acute treatment of migraine with or without aura in adults.
☛ Migraine Drugs Market Trends:
Growing adoption of CGRP inhibitors for preventive and acute migraine treatment.
Increasing use of digital health platforms for migraine tracking and personalized treatment.
Rising preference for self-administered and oral formulations for ease of use.
Biologics and monoclonal antibodies gaining traction in chronic migraine management.
Expansion of access to migraine drugs in emerging markets through e-pharmacies and telemedicine.
☛ Migraine Drugs Market Competitve Landscape:
Allergen, Eisai, Ltd., AstraZeneca plc, Abbott Laboratories, Eisai Co., Ltd., Endo International Plc., GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., and Johnson & Johnson among others.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/migraine-drugs-market
☛ Segment Covered in the Migraine Drugs Market:
By Type: Abortive Medicine, Preventive Medicine.
By Route of Administration: Oral, Injectable, Others.
By Distribution Channel: Hospital-Based Pharmacies, Retail Pharmacies, Online Pharmacies.
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Migraine Drugs Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=migraine-drugs-market
☛ Regional Analysis for Migraine Drugs Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
☛ Frequently asked questions:
âž What is the global sales, production, consumption, import, and export value of the Migraine Drugs Market?
âž Who are the key global manufacturers, and what is their operational performance?
âž What are the major opportunities and threats in the global Migraine Drugs Market?
âž Which product types or end-users show the most growth potential and market share?
âž What challenges and constraints are impacting the Migraine Drugs Market?
âž What sales, marketing, and distribution channels are used globally?
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market 2024-2031: Advancements in CGRP Inhibitors, Biologics, and Targeted Therapies Driving Exponential Growth | AstraZeneca plc, Abbott Laboratories, Eisai Co., Ltd here
News-ID: 4194392 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Brucellosis Vaccines Market Outlook: Advancements in Subunit, Mult …
Global Brucellosis Vaccines Market was valued at USD 323.45 million in 2021. It is forecasted to reach High by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.
The Brucellosis Vaccines Market includes vaccines designed to prevent Brucella infections in livestock and humans. These vaccines help reduce economic losses in agriculture and limit zoonotic transmission. Market growth is driven by increasing awareness of animal and public health, rising…
United States Personalized Cancer Vaccines Market Trends and Opportunities: Leve …
The global personalized cancer vaccines market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market focuses on vaccines tailored to individual patients' tumor profiles to stimulate the immune system against cancer cells. These vaccines leverage genomic and proteomic data to provide…
Japan Pharmaceutical Vials Market Outlook: Multi-Dose, Prefilled, and Advanced P …
Global Pharmaceutical Vials by DataM Intelligence estimates the market to grow at CAGR of 7.15% during the forecast period 2024-2031.
The Pharmaceutical Vials Market includes glass or plastic containers used to store injectable drugs, vaccines, and biologics under sterile conditions. Vials ensure drug stability, safety, and compliance with regulatory standards. Market growth is driven by increasing vaccine production, rising demand for biologics, and innovations in packaging design such as prefilled…
United States Robotic Dentistry Market Growth and Innovations: How AI, 3D Imagin …
The Robotic Dentistry Market is expected to grow at a CAGR of 21.6% during the forecasting period 2024-2031.
The robotic dentistry market is growing rapidly, driven by advancements in robotic-assisted dental procedures, offering increased precision, reduced patient recovery time, and enhanced treatment outcomes. Robotics in dentistry is increasingly used for procedures like implants, surgery, and root canal treatments. The market is fueled by technological innovations, rising demand for minimally invasive treatments,…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
